Why This Billionaire Built His Own $50 Million Private Golf Course

Key Concepts

• Halpert National: A private, Tom Fazio-designed golf course built by David Halpert in Granberry, Texas, emphasizing a "no budget" approach and personal passion.
• Caris Life Sciences: A multi-billion dollar public company founded by David Halpert, focused on personalized medicine, extending life, and improving patient quality of life through AI-driven genomic and transcriptomic analysis of cancer and other diseases.
• Next Generation Sequencing (NGS): A high-throughput technology used by Caris to analyze DNA and RNA, including whole exome and whole transcriptome sequencing.
• AI Insights: Caris's proprietary artificial intelligence algorithms that analyze vast datasets to identify unique genetic signatures for disease diagnosis and treatment selection.
• "Mom Rule": David Halpert's guiding principle for Caris, stating that every patient should be treated as if they were his own mother, ensuring no compromise on patient care for profit.
• Trojan Horse Strategy: Caris's business model of generating revenue from one service (e.g., diagnostic testing) while simultaneously developing and funding more ambitious, long-term projects (e.g., immunotherapy).
• Entrepreneurial Drive: The belief that entrepreneurs primarily need opportunity and capital, not necessarily formal education, exemplified by successful dropouts and Halpert's own journey.

---

Introduction & David Halpert's Background

The discussion features Chris Helman, a senior editor at Forbes, interviewing David Halpert at his private golf course, Halpert National, in Granberry, Texas, approximately 60 miles southwest of DFW airport. David Halpert is a highly successful entrepreneur, known for selling his first public company, Advanced PCS, about 20 years ago, and more recently for the IPO of Caris Life Sciences, which achieved a market capitalization of $10.3 billion. Halpert's career demonstrates a pattern of significant business achievements, followed by ambitious personal and professional ventures.

Halpert National Golf Course: A Passion Project

David Halpert's decision to build Halpert National stemmed from a casual idea by his wife in 2004, who desired a private course across their lake for unpressured play. Initially conceived as a par-three course, the project evolved significantly.

• Design and Collaboration: The course is a Tom Fazio design. Halpert, a member of four Fazio clubs, considers Fazio the "greatest designer in the history of man," noting Fazio has 47 of the top 200 courses globally. Halpert actively collaborated with Fazio, who is known for being open to input, unlike some other designers. The process involved many individuals, including Integrity Golf's Jade Work and shaper Jason, who operates the bulldozer.
• Season of Life: Halpert described building the course as a "season of his life," undertaking it at 67 years old while Fazio was 77, emphasizing a "do it now" mentality. He learned extensively about seasonality in planting and construction.
• "No Budget" Approach: Halpert explicitly told Fazio there was "no budget," allowing Fazio to build his ideal course without the constraints typically imposed by membership committees or real estate developers. This freedom allowed for a challenging design, with Halpert aiming for a total length of 7,777 yards (currently 7,500 yards, with plans for new tees to reach the target, including a 260-yard par three and a 620-yard par five).
• Current Status and Future Vision: The course is private, currently in its first full summer of "grow-in," with native grasses taking 12-18 months to mature. While there is no traditional clubhouse, future plans include a lodge, a party barn, four cabins, a porch, walking trails, and a playground. Halpert has stocked three lakes with Texas bass and a larger lake with Florida genetically modified bass (up to 18 pounds). He intends for the course to be played, inviting all touring pros who are members at Dallas National. He envisions his granddaughter having her wedding in the party barn.
• Cost and Maintenance: Halpert acknowledged the project's significant cost, stating it's "probably" millions of dollars a year to maintain, comparable to his flight crew expenses. He noted that the initial costs were "a little bit" more than anticipated but expects them to align with projections once the course is fully grown in.

Caris Life Sciences: Revolutionizing Personalized Medicine

After selling Advanced PCS for $7.5 billion (a startup that grew to Fortune 250, reporting 38 consecutive record EPS quarters with 85% compounded growth), Halpert sought a new challenge. He started four companies, with Caris Life Sciences being the most significant.

• Mission and Philosophy: Caris was founded on the idea of making personalized medicine a reality, focusing solely on "improving the quality of life and extending life" for patients. This mission was deeply influenced by J.H. Whitney founder Beno Schmidt, who, as the first SAR for the war on cancer, emphasized avoiding potential compromises of patient care for profit. Halpert countered that many non-profit healthcare providers were dysfunctional, leading him to develop the "Mom Rule": "We treat every patient as if they're your mom," ensuring no compromise on patient care and striving for superior outcomes.
• "Trojan Horse Strategy": Lacking an initial business plan for profitability, Halpert theorized that if they genuinely extended lives, a payment model would emerge. This led to the "Trojan horse strategy": performing one service (e.g., molecular interrogation of cancer cells from biopsies) for which they could be paid, while simultaneously building a vast database and developing more advanced solutions.
• Technological Approach: Halpert, initially not a doctor or scientist, acted as CSO for two years, designing experiments and learning extensively about nucleic acids, amino acids, proteins, DNA, and RNA.
  • Early Focus: Started with protein analysis (IHCs).
  • Next Generation Sequencing (NGS): Adopted NGS in 2011 (company started in 2008), which opened up new opportunities.
  • Comprehensive Data Collection: Caris interrogates cancer cells molecularly to determine effective therapies. Their database contains over 800,000 samples, with almost 600,000 having whole exome and whole transcriptome sequencing (analyzing all 22,000 coding genes for both DNA and mRNA), along with treatment and outcomes data.
• AI-Driven Insights: Caris leverages AI to analyze this extensive data.
  • Disease Detection (e.g., Breast Cancer): For a breast cancer blood test, they collected pristine samples from 700 women with breast cancer and 3,300 without. All genes are run, uploaded to the cloud, and an AI identifies distinguishing features. A second AI, "Dean," scores these features to create a signature that maximizes performance in calling breast cancer.
  • Therapy Selection (e.g., Colon Cancer): For late-stage colon cancer, Caris developed a 67-gene signature (DNA only) that, when used to direct therapy (Full First vs. Full Fury), "more than doubled overall survival" for patients. Halpert noted that only 25 of these 67 genes were even on competitors' panels, highlighting the inadequacy of limited panels.
  • Immunotherapy Development: The identified genetic signatures and targets can lead to the design of specific, personalized immunotherapies, which can then be injected like a vaccine to stimulate the immune system to target and kill diseased cells.
  • Impact: Caris generates new "AI insights" about once a month for various cancers (lung, breast, ovarian), often "doubling overall survival" by guiding drug selection.
• Future Outlook: Halpert confidently predicts Caris will become a "multi-trillion dollar company" due to its unique approach and proximity to launching these treatment products, stating "there's no one else working on this in the world."

Entrepreneurial Philosophy & Funding

Halpert's journey underscores a distinct entrepreneurial philosophy:

• Education vs. Opportunity & Capital: Halpert asserts, "Entrepreneurs don't need education. They just need opportunity and capital." He cites examples like Larry Ellison (no GED), Bill Gates (college freshman dropout), and Michael Dell (freshman dropout) to support this view, contrasting with his own lack of "fancy school" education.
• Self-Funding and Persistence: When seeking outside investors for Caris, Halpert faced significant challenges, with JP Morgan failing to secure a single bite after 28 meetings. Consequently, he invested $500-600 million of his own money, which he raised by selling three other companies he had started for a collective $1.2 billion (a 7x weighted return). This self-funding allowed him to retain 44% ownership post-IPO, an unusual feat for a founder.
• Vision-Driven: His approach to Caris was not initially driven by a business plan but by the conviction that if they did enough good, they would eventually be compensated.

Logical Connections & Analogies

Halpert drew a connection between golf and healthcare, noting that just as every golf shot must be customized for a particular hole, Caris customizes medicine for each patient. He also likened the golf course construction to an artist's project, acknowledging that a true artist's work is "never finished," reflecting his ongoing plans for Halpert National.

Conclusion

David Halpert's narrative is one of relentless entrepreneurial drive, profound personal passion, and a deep commitment to making a significant impact. From building a "no budget" dream golf course with a legendary designer to pioneering personalized medicine with AI and comprehensive genomic data, Halpert exemplifies a vision-driven approach. His "Mom Rule" for Caris and his belief that "Entrepreneurs don't need education. They just need opportunity and capital" encapsulate his unique blend of ethical conviction, innovative thinking, and self-reliant execution, positioning Caris Life Sciences for potentially transformative advancements in global healthcare.